Schroder Investment Management Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-28,593
Closed -$5.25M 1599
2021
Q2
$5.25M Buy
28,593
+3,185
+13% +$585K 0.01% 815
2021
Q1
$3.89M Sell
25,408
-72,547
-74% -$11.1M 0.01% 869
2020
Q4
$15.3M Sell
97,955
-46,448
-32% -$7.26M 0.02% 542
2020
Q3
$16.1M Buy
144,403
+35,038
+32% +$3.91M 0.03% 476
2020
Q2
$12.3M Sell
109,365
-137,525
-56% -$15.4M 0.02% 525
2020
Q1
$23.7M Sell
246,890
-74,995
-23% -$7.19M 0.05% 335
2019
Q4
$34.8M Buy
321,885
+98,073
+44% +$10.6M 0.06% 356
2019
Q3
$21.9M Buy
+223,812
New +$21.9M 0.04% 439
2018
Q1
Sell
-33,939
Closed -$4.06M 1361
2017
Q4
$4.06M Buy
33,939
+4,163
+14% +$498K 0.01% 808
2017
Q3
$4.12M Hold
29,776
0.01% 792
2017
Q2
$3.65M Buy
+29,776
New +$3.65M 0.01% 772
2017
Q1
Sell
-22,148
Closed -$2.71M 1282
2016
Q4
$2.71M Buy
22,148
+15,839
+251% +$1.94M 0.01% 797
2016
Q3
$773K Sell
6,309
-4,882
-44% -$598K ﹤0.01% 943
2016
Q2
$1.31M Sell
11,191
-12,379
-53% -$1.45M ﹤0.01% 877
2016
Q1
$3.18M Hold
23,570
0.01% 761
2015
Q4
$4.5M Sell
23,570
-5,121
-18% -$977K 0.01% 766
2015
Q3
$4.49M Buy
28,691
+738
+3% +$115K 0.01% 756
2015
Q2
$4.97M Buy
27,953
+183
+0.7% +$32.5K 0.01% 736
2015
Q1
$5.02M Sell
27,770
-2,900
-9% -$524K 0.01% 758
2014
Q4
$5.68M Buy
30,670
+2,176
+8% +$403K 0.01% 766
2014
Q3
$4.72M Hold
28,494
0.01% 789
2014
Q2
$4.45M Buy
28,494
+3,955
+16% +$618K 0.01% 785
2014
Q1
$3.73M Buy
24,539
+8,300
+51% +$1.26M ﹤0.01% 829
2013
Q4
$2.16M Buy
16,239
+7,808
+93% +$1.04M ﹤0.01% 923
2013
Q3
$979K Sell
8,431
-4,666
-36% -$542K ﹤0.01% 1019
2013
Q2
$1.21M Buy
+13,097
New +$1.21M ﹤0.01% 973